SG Americas Securities’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,375
| Closed | -$73K | – | 2755 |
|
|
2025
Q1 | $73K | Sell |
25,375
-5,067
| -17% | -$14.6K | ﹤0.01% | 2775 |
|
|
2024
Q4 | $143K | Sell |
30,442
-2,577
| -8% | -$12.1K | ﹤0.01% | 2180 |
|
|
2024
Q3 | $118K | Buy |
33,019
+6,926
| +27% | +$24.8K | ﹤0.01% | 2614 |
|
|
2024
Q2 | $162K | Buy |
26,093
+13,887
| +114% | +$86.2K | ﹤0.01% | 2011 |
|
|
2024
Q1 | $115K | Buy |
+12,206
| New | +$115K | ﹤0.01% | 2170 |
|
|
2023
Q2 | – | Sell |
-24,951
| Closed | -$71K | – | 2258 |
|
|
2023
Q1 | $71K | Buy |
24,951
+8,918
| +56% | +$25.4K | ﹤0.01% | 2737 |
|
|
2022
Q4 | $117K | Buy |
16,033
+4,198
| +35% | +$30.6K | ﹤0.01% | 2372 |
|
|
2022
Q3 | $96K | Sell |
11,835
-1,338
| -10% | -$10.9K | ﹤0.01% | 2568 |
|
|
2022
Q2 | $65K | Buy |
13,173
+8,884
| +207% | +$43.8K | ﹤0.01% | 2933 |
|
|
2022
Q1 | $101K | Sell |
4,289
-7,563
| -64% | -$178K | ﹤0.01% | 2458 |
|
|
2021
Q4 | $210K | Sell |
11,852
-7,376
| -38% | -$131K | ﹤0.01% | 2393 |
|
|
2021
Q3 | $542K | Buy |
+19,228
| New | +$542K | ﹤0.01% | 2222 |
|
|
2020
Q3 | – | Sell |
-6,862
| Closed | -$126K | – | 2425 |
|
|
2020
Q2 | $126K | Buy |
+6,862
| New | +$126K | ﹤0.01% | 2785 |
|